Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 2005Respiratory Care

Antimicrobial Treatment of Ventilator-Associated Pneumonia

View Full Paper
Ask AI
Bookmark
Share

Authors

DPDavid R. ParkUniversity of Washington

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

David R. Park (2005) studied this question.

synapsesocial.com/papers/6a9f65e822052d0ba76901a1https://doi.org/10.4187/respcare.05500932
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impact of BAL Data on the Therapy and Outcome of Ventilator-Associated Pneumonia1997 · 923 citations
  2. 2The role of oxygen limitation in the resistance of agar-entrapped, sessile-like Escherichia coli to aminoglycoside and β-lactam antibiotics1995 · 67 citations
  3. 3Enhanced susceptibility of Escherichia coli to intracellular killing by human polymorphonuclear leukocytes after in vitro incubation with chloramphenicol1981 · 20 citations
  4. 4Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients1993 · 1,105 citations
  5. 5Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults2003 · 1,411 citations